Reference Hub: Long-term outlook for Endometrial Cancer after Tamoxifen

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

In-depth resource

A Closer Look at Long-term outlook for Endometrial Cancer after Tamoxifen

In-depth context and analysis on this topic for researchers and advocates.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.